Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date01 Jan 1999 |
Establishment and validation of prognosis prediction model for patients with stable vitiligo
100 Clinical Results associated with Xinjiang Uyghur Medicine Hospital
0 Patents (Medical) associated with Xinjiang Uyghur Medicine Hospital
100 Deals associated with Xinjiang Uyghur Medicine Hospital
100 Translational Medicine associated with Xinjiang Uyghur Medicine Hospital